Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Massive Bio
Trialbee and Massive Bio Join Forces to Improve Clinical Trial Access and Patient Recruitment for Oncology and Hematology
January 31, 2024
From
Massive Bio
Via
Business Wire
Further Group Collaborates with Massive Bio, Integrating Health Solutions for the Insurance Industry to Boost Access to Cancer Clinical Trials Globally
November 08, 2023
From
Massive Bio
Via
Business Wire
Massive Bio Partners with Asklepieia, BeStrong, and Open Health Alliance in Greece to Enhance Cancer Clinical Trial
August 02, 2023
From
Massive Bio
Via
Business Wire
Massive Bio and CureMatch Announce Groundbreaking Partnership to Revolutionize Cancer Treatment through AI and Clinical Trial Accessibility
July 18, 2023
From
Massive Bio
Via
Business Wire
Reigniting the Cancer Moonshot: Massive Bio Joins CancerX as Founding Member to Accelerate Innovation and AI Implementation in Cancer Care
June 04, 2023
From
Massive Bio
Via
Business Wire
Massive Bio and The Oncology Institute (TOI) Forge Partnership to Revolutionize Cancer Care and AI-enabled Cancer Research
June 03, 2023
From
Massive Bio
Via
Business Wire
Precision Cancer Consortium Teams Up with Massive Bio to Utilize AI Analytics and Enhance Clinical Trial Matching for Cancer Patients Worldwide
June 02, 2023
From
Massive Bio
Via
Business Wire
Massive Bio Launches Revolutionary ChatGPT-Powered Chatbot Platform at ASCO 2023 to Simplify and Expand Access to Oncology Clinical Trials
June 01, 2023
From
Massive Bio
Via
Business Wire
Massive Bio Accelerates Its Expansion in the European Union, Driven by New Clinical Trials Regulations
March 29, 2023
From
Massive Bio
Via
Business Wire
Clinical Trials Demystified by Massive Bio’s Chief Medical Officer
February 28, 2023
From
Massive Bio
Via
Business Wire
Massive Bio is named to the New York City Digital Health 100
February 03, 2023
From
Massive Bio
Via
Business Wire
Massive Bio Announces Plans to Expand AI Use in Oncology, from Clinical Trial Matching to Drug Matching and Beyond
January 04, 2023
From
Massive Bio
Via
Business Wire
Massive Bio Reaffirms Global Growth Strategy with Key C-Suite Hires and Executive Director Appointments
December 15, 2022
From
Massive Bio
Via
Business Wire
Massive Bio and Azra AI to Expand AI’s Potentially Lifesaving Impact on Cancer Patients
November 10, 2022
From
Massive Bio
Via
Business Wire
Massive Bio Onboards Over 100,000 Cancer Patients to Find Their Clinical Trial, Powered by Artificial Intelligence
October 26, 2022
From
Massive Bio
Via
Business Wire
Massive Bio Nominated for Prestigious Digital Health Award
October 07, 2022
From
Massive Bio
Via
Business Wire
Massive Bio and Perthera.ai Partner to Empower Cancer Patients with Personalized Therapies and Accurate Trial Recommendations
October 05, 2022
From
Massive Bio
Via
Business Wire
Massive Bio Continues to Grow in Europe
September 23, 2022
From
Massive Bio
Via
Business Wire
AdhereTech and Massive Bio, Two of NYC Digital Health 100 most Promising Start-Ups, Announce AI-Enabled, Patient-Centric Oncology Solutions Partnership
June 07, 2022
From
Massive Bio
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.